Can a helping hand ease the leap to adult transplant care?

NCT ID NCT06386198

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This pilot study tests whether adding a health advocate to the transplant team helps young adults (ages 18-25) who received a liver transplant more than a year ago and are about to move to adult care. The advocate helps address social needs like food insecurity, improves communication with doctors, and coordinates care. The study measures whether this support is acceptable and feasible, and whether it improves patient experience and medication adherence.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Health Advocate (Patient Navigator) - a behavioral intervention providing support with social needs, communication, and care coordination
What this could lead to
If successful, this could establish a support model that helps young liver transplant patients manage their health and transition smoothly to adult care, potentially improving long-term outcomes.
What could go wrong
This is a small pilot study (20 participants) focused on feasibility, not proof of effectiveness. Results may not generalize, and the intervention's impact on clinical outcomes is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANT; COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Healthcare of Atlanta

    RECRUITING

    Atlanta, Georgia, 30345, United States

  • University of California San Francisco

    RECRUITING

    San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.